Role of transcription factor Sp1 in the quercetin-mediated inhibitory effect on human malignant pleural mesothelioma

International Journal of Molecular Medicine

Volumn 30, Issue 4, 2012, Pages 835-841

  Chae, Jung Il ^a   Cho, Jin Hyoung ^a   Lee, Kyung Ae ^b   Choi, Nag Jin ^a   Seo, Kang Seok ^c   Kim, Sang Bum ^d   Lee, Sang Han ^b   Shim, Jung Hyun ^b  

^a Chonbuk National University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Sunchon National University   (South Korea)

^d National Institute of Animal Science   (South Korea)

Author keywords

Anticancer; Apoptosis; Human malignant pleural mesothelioma; Quercetin; Specificity protein 1

Indexed keywords

CASPASE 3; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL XL; PROTEIN BID; QUERCETIN; TRANSCRIPTION FACTOR SP1;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; QUERCETIN; SP1 TRANSCRIPTION FACTOR;

EID: 84866524286     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1075     Document Type: Article

References (43)

1. Miean KH and Mohamed S: Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 49: 3106-3112, 2001.
2. Kim GN and Jang HD: Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells. Ann NY Acad Sci 1171: 530-537, 2009.
3. Hirpara KV, Aggarwal P, Mukherjee AJ, Joshi N and Burman AC: Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anticancer Agents Med Chem 9: 138-161, 2009.
4. Wang L, Tu YC, Lian TW, Hung JT, Yen JH and Wu MJ: Distinctive antioxidant and antiinflammatory effects of flavonols. J Agric Food Chem 54: 9798-9804, 2006. (Pubitemid 46158973)
5. Jakobsen JN and Sorensen JB: Review on clinical trials of targeted treatments in malignant mesothelioma. Cancer Chemother Pharmacol 68: 1-15, 2011.
6. Toyokuni S: Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci 71: 1-10, 2009.
7. Li L and Davie JR: The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 192: 275-283, 2010.
8. Kong LM, Liao CG, Fei F, Guo X, Xing JL and Chen ZN: Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer. Cancer Sci 101: 1463-1470, 2010.
9. Sankpal UT, Goodison S, Abdelrahim M and Basha R: Targeting Sp1 transcription factors in prostate cancer therapy. Med Chem 7: 518-525, 2011.
10. Archer MC: Role of sp transcription factors in the regulation of cancer cell metabolism. Genes Cancer 2: 712-719, 2011.
11. Wan J, Carr BA, Cutler NS, Lanza DL, Hines RN and Yost GS: Sp1 and Sp3 regulate basal transcription of the human CYP2F1 gene. Drug Metab Dispos 33: 1244-1253, 2005. (Pubitemid 41043769)
12. Bai X and Deng H: Research progress on relationship between transcription factor Sp1 and tumor. Zhejiang Da Xue Xue Bao Yi Xue Ban 39: 215-220, 2010 (In Chinese).
13. Culver C, Melvin A, Mudie S and Rocha S: HIF-1alpha depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs. Cell Cycle 10: 1249-1260, 2011.
14. Gibellini L, Pinti M, Nasi M, et al: Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med 2011: 591356, 2011.
15. Linsalata M, Orlando A, Messa C, Refolo MG and Russo F: Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesis. Anticancer Res 30: 3501-3507, 2010.
16. Russo M, Spagnuolo C, Volpe S, Mupo A, Tedesco I and Russo GL: Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients. Br J Cancer 103: 642-648, 2010.
17. Thangasamy T, Sittadjody S, Mitchell GC, et al: Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73. BMC Cancer 10: 282, 2010.
18. Gonzalez-Gallego J, Garcia-Mediavilla MV, Sanchez-Campos S and Tunon MJ: Fruit polyphenols, immunity and inflammation. Br J Nutr 104 (Suppl 3): S15-S27, 2010.
19. Shim JH, Choi HS, Pugliese A, et al: (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase. J Biol Chem 283: 28370-28379, 2008.
20. Zykova TA, Zhu F, Zhai X, et al: Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog 47: 797-805, 2008.
21. Choi ES, Shim JH, Jung JY, et al: Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1. Cancer Sci 102: 742-748, 2011.
22. Shim JH, Shin JA, Jung JY, et al: Chemopreventive effect of tolfenamic acid on KB human cervical cancer cells and tumor xenograft by downregulating specificity protein 1. Eur J Cancer Prev 20: 102-111, 2011.
23. Vachani A, Moon E, Wakeam E and Albelda SM: Gene therapy for mesothelioma and lung cancer. Am J Respir Cell Mol Biol 42: 385-393, 2010.
24. Vachani A, Moon E, Wakeam E, Haas AR, Sterman DH and Albelda SM: Gene therapy for lung neoplasms. Clin Chest Med 32: 865-885, 2011.
25. Choi ES, Cho SD, Jeon JG and Cho NP: The apoptotic effect of the hexane extract of Rheum undulatum L. in oral cancer cells through the down-regulation of specificity protein 1 and survivin. Lab Anim Res 27: 19-24, 2011.
26. Chiefari E, Brunetti A, Arturi F, et al: Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation? BMC Cancer 2: 35, 2002.
27. Hosoi Y, Watanabe T, Nakagawa K, et al: Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 25: 461-468, 2004.
28. Wang L, Wei D, Huang S, et al: Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371-6380, 2003. (Pubitemid 38031822)
29. Yao JC, Wang L, Wei D, et al: Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 10: 4109-4117, 2004. (Pubitemid 38812490)
30. Zannetti A, Del Vecchio S, Carriero MV, et al: Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 60: 1546-1551, 2000. (Pubitemid 30183423)
31. Shukla Y and George J: Combinatorial strategies employing nutraceuticals for cancer development. Ann NY Acad Sci 1229: 162-175, 2011.
32. Zamin LL, Filippi-Chiela EC, Dillenburg-Pilla P, Horn F, Salbego C and Lenz G: Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci 100: 1655-1662, 2009.
33. Murakami A, Ashida H and Terao J: Multitargeted cancer prevention by quercetin. Cancer Lett 269: 315-325, 2008.
34. Ranelletti FO, Maggiano N, Serra FG, et al: Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. Int J Cancer 85: 438-445, 2000. (Pubitemid 30030420)
35. van Erk MJ, Roepman P, van der Lende TR, et al: Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr 44: 143-156, 2005. (Pubitemid 40585513)
36. Watson WH, Cai J and Jones DP: Diet and apoptosis. Annu Rev Nutr 20: 485-505, 2000.
37. Shen SC, Chen YC, Hsu FL and Lee WR: Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. J Cell Biochem 89: 1044-1055, 2003.
38. Singhal RL, Yeh YA, Praja N, Olah E, Sledge GW Jr and Weber G: Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun 208: 425-431, 1995.
39. Chi YS, Jong HG, Son KH, Chang HW, Kang SS and Kim HP: Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases. Biochem Pharmacol 62: 1185-1191, 2001. (Pubitemid 33055622)
40. Ong CS, Tran E, Nguyen TT, et al: Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncol Rep 11: 727-733, 2004.
41. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA and Miller DM: Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88: 1613-1621, 1991.
42. Chintharlapalli S, Papineni S, Lei P, Pathi S and Safe S: Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 11: 371, 2011.
43. Pietrzak M and Puzianowska-Kuznicka M: p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter. Biol Chem 389: 383-393, 2008. (Pubitemid 351773909)